Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hanwha Systems (272210) – Signs KRW 142.1B Contract with DAPA for TICN System PBL Project

Posted on June 18, 2024July 22, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Systems (272210) – Signs KRW 142.1B Contract with DAPA for TICN System PBL Project

Fact Source: Financial Supervisory Service DART / 2024-06-18

Disclosure Type: Sales / Supply Contract

💡 3-Second Summary

Hanwha Systems has signed a supply contract worth approximately KRW 142.1B with the Defense Acquisition Program Administration (DAPA) for the ’24 Tactical Information Communication Network (TICN) System PBL Project.

📊 1. [Key Disclosure Details & Financial Figures]

  • Contract Title: ’24 Tactical Information Communication Network (TICN) System PBL Project
  • Contract Amount: KRW 142,062,000,000 (including VAT) / Approx. KRW 142.1B
  • Percentage of Recent Revenue: 5.79% (Based on 2023 consolidated revenue of KRW 2,453,079,541,922 / Approx. KRW 2.45T)
  • Counterparty: Defense Acquisition Program Administration (DAPA)
  • Sales / Supply Region: Domestic (South Korea)
  • Contract Period: June 18, 2024 ~ April 30, 2029
  • Key Terms: Contract amount and contract period are subject to change depending on project progress

📈 2. [Expert View: What This Disclosure Means for Investors]

This filing confirms that Hanwha Systems has secured a supply contract with DAPA for the “’24 Tactical Information Communication Network (TICN) System PBL Project”.

The contract value of KRW 142.1B represents 5.79% of the company’s 2023 consolidated revenue. Spanning approximately 4 years and 10 months from June 18, 2024, to April 30, 2029, the revenue is set to be recognized incrementally over the contract duration based on project execution. As noted in the filing, the total contract value and timeframe remain subject to potential adjustments as the project progresses.

📝 Editor’s Comment (by K-STOCK Editor)

When evaluating sales and supply contract filings, it is important to examine the total deal size alongside the execution schedule and potential modification clauses. This disclosure outlines a domestic long-term contract with DAPA scheduled to be executed over approximately 4 years and 10 months.

For investors, the key monitoring point is tracking whether the contract moves forward within the designated timeframe without structural revisions. Additionally, paying attention to any subsequent regulatory disclosures regarding potential modifications to the contract amount or duration will serve as a primary reference point.

📢 Disclaimer & Source Notice

Source: This content was structured and newly generated based on official filing data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Celltrion (068270) Obtains European EMA Approval for Phase 3 Clinical Trial Plan Part 1 of ‘CT-P13 SC (Remsima SC)’ in Pediatric Ulcerative Colitis Patients
Next Post: [Disclosure] Hanamicron (067310) Ex-Rights Date Notice (Rights Offering) – Base Price: KRW 22,950

Related Posts

[Disclosure] Hanwha Ocean (042660) Files Amendment to Convene Annual General Meeting of Shareholders, Correcting Background Details for Outside Director and Audit Committee Nominee Hyo-Jin Lee Disclosures
[Disclosure] Celltrion (068270) Reports FY2025 Consolidated Revenue of KRW 4.16T and Operating Profit of KRW 1.17T, Surge of 137.49% YoY on Improved Cost Structure Disclosures
[Disclosure] Hanwha Aerospace (012450) – (Correction) Change in Revenue or Profit/Loss Structure over 30% (Clerical Error Correction & FY2023 Consolidated Revenue KRW 9.37T, Operating Profit KRW 701.7B) Disclosures
[Disclosure] Alteogen (196170) Signs Exclusive License Agreement with AstraZeneca Subsidiary for ALT-B4 Valued up to USD 600M (KRW 872.9B) Disclosures
[Disclosure] Hanwha Aerospace (012450) Announces Fatal Accident at Geoje Shipyard of Major Subsidiary Hanwha Ocean Co., Ltd. Disclosures
[Disclosure] Hanwha Aerospace (012450) – Notice of Q1 2024 Earnings Conference Call and Webcast Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme